Cite
HARVARD Citation
Scoto, M. et al. (n.d.). G299 Nusinersen (spinraza) is the first drug approved for spinal muscular atrophy (sma): initial experience in patients with sma type 1 treated in the expanded access program (eap). Archives of disease in childhood. p. A122. [Online].